Combining PRP with fat and bone marrow for treating osteoarthritis
Official title: A Phase II, Randomized, Parallel-Group Study to Investigate the Combined Use of PRP with Lipoaspirate And/or Bone Marrow Aspirate in Osteoarthritis
Run by Pagdin Health · NCT03984461 · Data updated 2026-11-12
This study is testing whether combining platelet-rich plasma with fat or bone marrow can help people with osteoarthritis feel better in their major joints.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 19 Years to 79 Years |
| Sex | All |
| Enrollment | 240 (estimated) |
| Sponsor | Pagdin Health Academic / other |
| Locations | 1 site (Kelowna, British Columbia) |
| Status | Recruiting |
| Started | September 1, 2020 |
| Main results expected | December 2027 |
| Study ends | December 2027 |
| Registry record updated | November 15, 2024 |
| Trial ID | NCT03984461 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 19 and older with evidence of osteoarthritis in a major joint and Kellgren & Lawrence Grades 1-3.
✕Probably not a fit
Patients with severe osteoarthritis (Grade 4), high BMI, or recent joint surgeries may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to evaluate the effectiveness of combining platelet-rich plasma (PRP) with lipoaspirate and/or bone marrow aspirate in treating osteoarthritis in major joints. A total of 240 participants will be randomly assigned to one of three treatment groups: one receiving PRP plus lipoaspirate, another receiving PRP plus bone marrow aspirate, and the last group receiving all three treatments together. The outcomes of these combinations will be compared to determine the most effective approach for alleviating symptoms of osteoarthritis.
Why it matters
Potential benefit: If successful, this treatment could significantly improve joint function and reduce pain for patients suffering from osteoarthritis.
How similar studies have gone: Other studies have shown promising results with similar combinations of biologic therapies for osteoarthritis, indicating potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Capable of providing written informed consent and willing and able to adhere to all protocol requirements. 2. Male or female at least 19 years of age at the time of providing written informed consent. 3. Evidence of OsteoArthritis in a major joint requires recent (within one year) imaging, either by x-ray or MRI. Kellgren \& Lawrence Grades 1-3 are accepted for participation. Exclusion Criteria: 1. BMI \> 35 2. Arthroscopic surgery to the treatment joint within 12 months 3. Cortisone or HA injection within the last 3 months prior to stem cell injection 4. Inability to hold antiplatelet therapy according to treating provider prior to procedure 5. Kellgren \& Lawrence Grade 4 Osteoarthritis 6. Participants with a platelet count less than 100 x 109 7. Participants with a Hemoglobin less than 100 g/L 8. Participants who have an active Infection with fever and/or elevated white blood cell (WBC) count 9. Participants with an active Cancer diagnosis. 10. Participants with autoimmune disorders including rheumatoid arthritis and lupus. 11. Women who are pregnant will be excluded due to the possibility of fetal harm associated with x-rays. Should a participant become pregnant during the study, she will be withdrawn from further treatment and imaging, but can participate in symptom follow-up. Female participants of childbearing potential will be counseled at screening about contraception and encouraged to use birth control for the duration of the study. 12. Participants with allergies to lidocaine, heparin, or epinephrine.
Where it's running
-
Pagdin Health
Kelowna, British Columbia, Canada Recruiting
Study contacts
- Study coordinator: Grant Pagdin, MD
- Email: info@pagdinhealth.com
- Phone: 250-717-3200
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Autologous adipose-derived stem cell injections for knee osteoarthritis
We’re testing whether injecting a patient’s own fat-derived stem cells into the knee can help people with knee OA feel less pain and move better, compared with a standard hyaluronic acid treatment.
-
Early wear of a Vitamin E-infused liner in a dual-mobility hip replacement
This study tests whether a Vitamin E-infused liner in a dual-mobility hip implant wears as little as a conventional liner over two years in adults needing hip replacement.
-
Preoperative Music to Ease Anxiety Before Hip or Knee Replacement
Patients awaiting hip or knee replacement listen to their own music through noise‑canceling headphones to see if it lowers preoperative anxiety.
-
Weight-bearing dangling exercises vs VMOb NMES for knee osteoarthritis
This study tests whether weighted dangling exercises or VMOb muscle NMES help people with knee osteoarthritis.
-
Post-op prednisone vs standard steroid regimen after knee or hip replacement
This study tests a 5-day oral prednisone course after knee or hip replacement to see if pain, swelling, and glucose control are better or different than the usual intraoperative steroid approach.
-
AI-based prediction of five major diseases using integrated health data
Researchers are testing an AI model to see if they can predict the onset of five major diseases in adults 30–65 by combining medical records with biospecimens and lifestyle data.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.